Skip to main content

Imaging

  • Chapter
  • First Online:
  • 1167 Accesses

Abstract

Adrenal masses are commonly detected with the increasing use of cross-sectional imaging and are reported with a frequency of up to 5 % at general abdominal computed tomography (CT). In addition, they have an increasing incidence with age, as they are detected in about 0.2 % in young people and up to 7 % in the elderly.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Joung WF Jr (2007) The incidentally discovered adrenal mass. N Engl J Med 356:601–610

    Article  Google Scholar 

  2. Lockhart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112

    Article  PubMed  Google Scholar 

  3. Suzuki Y, Sasagawa S, Suzuki H et al (2001) The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int Urol Nephrol 32:303–306

    Article  PubMed  CAS  Google Scholar 

  4. Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340

    Article  PubMed  Google Scholar 

  5. Rush MF, Schneider G, Bhole RM et al (2008) Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions. AJR 191:1852–1860

    Article  Google Scholar 

  6. Mayo-Smith WW, Boland GW, Noto RB et al (2001) State-of-the-art adrenal imaging. RadioGraphics 21:995–1012

    PubMed  CAS  Google Scholar 

  7. Dunnick NR, Korobkin M (2002) Imaging of adrenal incidentalmomas. AJR Am J Roentgenol 179:559–568

    PubMed  Google Scholar 

  8. Boland GWL, Blake MA, Hahn PF et al (2008) Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 249(3):759–775

    Article  Google Scholar 

  9. Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental indeterminate adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168

    Article  PubMed  Google Scholar 

  10. Russell C, Goodacre BW, vanSonnenberg E et al (2000) Spontaneous rupture of adrenal myelolipoma: spiral CT appearance. Abdom Imaging 25:431–434

    Article  PubMed  CAS  Google Scholar 

  11. Korobkin M, Giordano TJ, Brodeur FJ et al (1996) Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743–747

    PubMed  CAS  Google Scholar 

  12. Lee MJ, Hahn PF, Papanicolaou N et al (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415–418

    PubMed  CAS  Google Scholar 

  13. Blake MA, Cronin CG, Boland GW (2010) Adrenal imaging. AJR 194:1450–1460

    Article  PubMed  Google Scholar 

  14. Heinz-Peer G, Memarsadeghi M, Niederle B (2007) Imaging of adrenal masses. Curr Opin Urol 17:32–38

    Article  Google Scholar 

  15. Korobkin M (2000) CT characterization of adrenal masses: the time has come. Radiology 217:629–632

    PubMed  CAS  Google Scholar 

  16. Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765

    Article  PubMed  Google Scholar 

  17. Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169:5–11

    Article  PubMed  Google Scholar 

  18. Ferrozzi F, Bova D (1995) CT and MR demonstration of fat within an adrenal cortical carcinoma. Abdom Imaging 20:272–274

    Article  PubMed  CAS  Google Scholar 

  19. Heye S, Woestenborghs H, Van Kerkhove F et al (2005) Adrenocortical carcinoma with fat inclusion: case report. Abdom Imaging 30:641–643

    Article  PubMed  CAS  Google Scholar 

  20. Mannelli M, Colagrande S, Valeri A et al (2011) Incidental and metastatic adrenal masses. Semin Oncol 37:649–661

    Article  Google Scholar 

  21. Fujiyoshi F, Nakajo M, Kukukura Y et al (2003) Characterization of adrenal tumors by chemical shift fast-low angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR 180:1649–1657

    PubMed  Google Scholar 

  22. Outwater EK, Siegelman ES, Radecki PD et al (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical shift MR imaging. AJR 165:579–583

    PubMed  CAS  Google Scholar 

  23. Ramalho M, de Campos RO, Heredia V et al (2011) Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques. AJR 197:415–423

    Google Scholar 

  24. Israel GM, Korobkin M, Wang C et al (2004) Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR 183:215–219

    PubMed  Google Scholar 

  25. Haider MA, Ghai S, Jhaveri K et al (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231:711–716

    Article  PubMed  Google Scholar 

  26. Blake MA, Kalra MK, Sweeney AT et al (2005) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585

    Article  PubMed  Google Scholar 

  27. Park BK, Kim CK, Kim B et al (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765

    Article  PubMed  Google Scholar 

  28. Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors. J Magn Reson Imaging 29:112–117

    Article  PubMed  Google Scholar 

  29. Miller FH, Wang Y, McCarthy RJ et al (2010) Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR 194:W179–W185

    Article  PubMed  Google Scholar 

  30. Gross MD, Korobkin M, Assaly WB et al (2009) Contemporary imaging of incidentally discovered adrenal masses. Nat Rev Urol 6:363–373

    Article  PubMed  Google Scholar 

  31. Wong KK, Komissarova M, Avram A et al (2010) Adrenal cortical imaging with I-131 NP-59 SPECT-CT. Clin Nucl Med 35:865–869

    Article  PubMed  Google Scholar 

  32. Lombardi CP, Raffaelli M, De Crea C et al (2007) Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery? Langebecks Arch Surg 392:623–628

    Article  Google Scholar 

  33. Henning J, Lindhe Ö, Bergström M et al (2006) [11C]-Metomidate positron emission tomography of adrenocortical tumours in correlation with histopathological findings. J Clin Endocrinol Metab 91:1410–1414

    Article  Google Scholar 

  34. Boland GWL, Dwamena B, Sangwaiya MJ et al (2011) Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 269:117–126

    Article  Google Scholar 

  35. Rufini V, Calcagni ML, Baum RP (2006) Imaging of neuroendocrine tumors. Semin Nucl Med 36:228–247

    Article  PubMed  Google Scholar 

  36. Jacobson AF, Deng H, Lombard J et al (2010) 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 95:2596–2606

    Article  PubMed  CAS  Google Scholar 

  37. Pacak K, Eisenhofer G, Goldstein DS (2004) Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568–580

    Article  PubMed  Google Scholar 

  38. Rufini V, Treglia G, Castaldi P et al (2011) Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun 32:575–582

    Article  PubMed  Google Scholar 

  39. Naswa N, Sharma P, Nazar AH, et al (2011) Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma. Preliminary results from a single centre study. Eur Radiol 22:710–719

    Google Scholar 

  40. Timmers HJ, Chen CC, Carrasquillo JA et al (2009) Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94:4757–4767

    Article  PubMed  CAS  Google Scholar 

  41. Timmers HJ, Kozupa A, Chen CC et al (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25:2262–2269

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Falchini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Falchini, M., Rufini, V. (2013). Imaging. In: Valeri, A., Bergamini, C., Bellantone, R., Lombardi, C. (eds) Surgery of the Adrenal Gland. Springer, Milano. https://doi.org/10.1007/978-88-470-2586-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2586-8_5

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2585-1

  • Online ISBN: 978-88-470-2586-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics